Another study focused on the relationship between BRMS1 promoter methylation and the prognosis of LC patients, suggesting that patients with BRMS1 promoter methylation had a significantly lower overall survival (OS) time and progression-free survival (PFS) time than those without BRMS1 promoter methylation [50]. The gene discussed is BRMS1; the disease is laryngotracheoesophageal cleft.